This is a pre-revenue technical validation with no disclosed contracts or revenue — the stock has historically declined on similar announcements (avg T+20 return -23.54% across prior reports). Monitor for actual commercial agreements or revenue guidance before treating this as a catalyst. The company's diversified business (medical, defense) adds uncertainty to the quantum narrative.
Price Chart
Executive Summary
QTREX announced that its proprietary printed coaxial quantum interconnect platform exceeded RF performance requirements set by strategic partners, including continuous broadband transmission from 10 MHz to 20 GHz, >68 dB crosstalk isolation, and picosecond-level timing precision. This technical validation removes a key scalability barrier for quantum computing infrastructure but is a pre-commercial milestone with no revenue or contract disclosed, and the company's historical stock performance on prior announcements has been poor.
Key Facts
- Proprietary coaxial quantum interconnect platform exceeded strategic partner RF performance requirements across all measured parameters.
- Continuous broadband transmission from 10 MHz to 20 GHz with no resonance or discontinuity.
- Crosstalk suppression maintained at minimum 68 dB below source signal across entire band.
- Channel-to-channel skew above 1 GHz of only 4.4 picoseconds; group delay spread of 2 picoseconds.
- Insertion-loss variation of 0.33 dB, impedance variation <0.3 ohms, forward/reverse transmission agreement within 0.06 dB.
- No revenue, contract, or financial figures disclosed in the press release.
- Company also has medical technology portfolio (respiratory support, blood monitoring) and AME applications for defense/aerospace.
Financial Impact
No financial figures disclosed; pre-commercial technical milestone with no revenue or contract value stated.
Risk Factors
- No revenue or contract disclosed — technical validation does not guarantee commercial adoption.
- Historical stock performance on prior announcements has been negative (avg T+20 -23.54%, 20% win rate).
- Company has multiple business lines (medical, defense, quantum) — quantum segment may not be the primary value driver.
- Forward-looking statements are aspirational; no timeline for commercialization provided.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3336830 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | 6-K | $0.8160 $0.6820 | ▼ −16.42% | ▼ −16.34% | $1.10 (+34.80%) |
Aug 21, 2026 6w ago | 424B5 | $0.9155 $0.8564 | ▲ +6.46% | ▲ +5.93% | $1.10 (−20.15%) |
Aug 19, 2026 6w ago | 6-K | $1.12 $0.8702 | ▼ −22.30% | ▼ −20.35% | $1.10 (−1.79%) |
Aug 3, 2026 8w ago | 6-K | $1.01 $0.8273 | ▼ −18.09% | ▼ −19.33% | $1.10 (+8.91%) |
Jul 31, 2026 9w ago | Press Release | $0.9000 $0.8340 | ▼ −7.33% | ▼ −10.32% | $1.10 (+22.22%) |
Jul 24, 2026 10w ago | 6-K | $0.9497 $0.8664 | ▼ −8.77% | ▼ −12.07% | $1.10 (+15.83%) |
Jul 22, 2026 10w ago | Press Release | $0.9060 $1.12 | ▲ +23.62% | ▲ +20.72% | $1.10 (+21.41%) |
Jul 17, 2026 11w ago | 6-K | $1.27 $0.9799 | ▼ −22.84% | ▼ −27.29% | $1.10 (−13.39%) |
Jul 17, 2026 11w ago | Press Release | $1.27 $0.9799 | ▼ −22.84% | ▼ −27.29% | $1.10 (−13.39%) |
Jul 14, 2026 11w ago | 6-K | $1.50 $0.9959 | ▼ −33.61% | ▼ −36.10% | $1.10 (−26.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access